Dr. Pablo García-Pavía joins Idoven as Medical Advisor to advance early detection of cardiac diseases

We are honored to welcome Dr. Pablo García-Pavía, a leading expert in hereditary heart diseases, as a Medical Advisor at Idoven. This collaboration represents a major step in our mission to harness the potential of AI-driven ECG analysis to enable earlier detection of cardiovascular conditions and support better treatment decisions, particularly for complex diseases like amyloidosis.

Dr. García-Pavía is a renowned cardiologist dedicated to advancing care for patients with hereditary and rare cardiac diseases. He leads the Inherited Cardiomyopathies Unit at Hospital Universitario Puerta de Hierro in Madrid and is a prominent researcher at the Spanish National Cardiovascular Research Centre (CNIC).

At Idoven, we are committed to developing the most advanced AI algorithms for improving patient outcomes. Our vision is to build a powerful network that bridges hospitals, industry leaders, and public institutions while generating robust clinical evidence in collaboration with top Key Opinion Leaders. This partnership with Dr. García-Pavía underscores our goal of delivering impactful solutions that integrate cutting-edge technology into healthcare and transform patients' lives worldwide.

Reflecting on this partnership, Dr. García-Pavía said: “My priority as a cardiologist has always been to improve patient outcomes, especially in hereditary or hard-to-detect diseases like amyloidosis. Idoven’s AI technology offers the potential for earlier and more precise diagnoses, and I’m excited to contribute to this transformative vision for cardiovascular care.”

Idoven’s AI technology offers the potential for earlier and more precise diagnoses, and I’m excited to contribute to this transformative vision for cardiovascular care.

- Dr. Pablo García Pavía, Head of the Inherited Cardiac Diseases and Heart Failure Unit at Hospital Puerta del Hierro

Manuel Marina Breysse, CEO, and co-founder of Idoven, emphasized the importance of this collaboration:  “Dr. García Pavía’s expertise will be key as we continue to develop advanced AI solutions for earlier and more effective heart disease detection. This partnership underscores our commitment to working with leading professionals to bring cutting-edge innovations to patients.”

Dr. García Pavía’s expertise will be key as we continue to develop advanced AI solutions for earlier and more effective heart disease detection.

- Manuel Marina Breysse, cardiologist, CEO and co-founder at Idoven

With over 300 peer-reviewed publications in prestigious journals such as The New England Journal of Medicine, Circulation, and the European Heart Journal, Dr. García-Pavía’s work has significantly advanced the understanding and treatment of cardiomyopathies, heart failure, and rare conditions like amyloidosis. His exceptional contributions continue to shape the field of cardiology and inspire progress in patient care.